Depreciation in USD of MiNK Therapeutics, Inc. from 2020 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
MiNK Therapeutics, Inc. quarterly/annual Depreciation history and change rate from 2020 to Q1 2025.
  • MiNK Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2025 was $50,765.000, a 5.7% decline year-over-year.
  • MiNK Therapeutics, Inc. annual Depreciation for 2024 was $215,437.000, a 5.29% increase from 2023.
  • MiNK Therapeutics, Inc. annual Depreciation for 2023 was $204,617.000, a 68.1% increase from 2022.
  • MiNK Therapeutics, Inc. annual Depreciation for 2022 was $121,749.000, a 56.2% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

MiNK Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $50,765 -$3,066 -5.7% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q1 2024 $53,831 +$8,145 +17.8% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q1 2023 $45,686 +$18,609 +68.7% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q1 2022 $27,077 +$10,883 +67.2% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q1 2021 $16,194 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022

MiNK Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $215,437 +$10,820 +5.3% 01 Jan 2024 31 Dec 2024 10-K 18 Mar 2025
2023 $204,617 +$82,868 +68.1% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025
2022 $121,749 +$43,789 +56.2% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 $77,960 +$22,900 +41.6% 01 Jan 2021 31 Dec 2021 10-K 24 Mar 2023
2020 $55,060 01 Jan 2020 31 Dec 2020 10-K 18 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.